8-K
filed August 8, 2024, 7:59 PM ET
CIK 0001501134
M&A
confidence high
sentiment negative
materiality 1.00
Invitae Corp: going-concern / distress — Invitae sells business to Labcorp for $239M, exits Chapter 11; stock canceled
Invitae Corp
- Labcorp subsidiary acquired Invitae's business for $239M cash plus assumed liabilities; closed Aug 5, 2024.
- Chapter 11 plan confirmed and effective Aug 7, 2024; all common stock canceled with no value.
- Board of directors dissolved; CEO Kenneth D. Knight, CFO Ana J. Schrank, and other officers dismissed.
- Debtors reported $394M total assets and $1,692M total liabilities as of June 30, 2024.
- All existing notes, indentures, and equity interests discharged and cancelled.
Key facts
Extracted from this filing and checked against the source text.
Distress & Bankruptcy
SEC 8-K Item 1.03
confidence 0.9
Invitae Corp entered chapter 11 in United States Bankruptcy Court District of New Jersey.
- Proceeding
- chapter 11
- Court
- United States Bankruptcy Court District of New Jersey
Exact text from the filing
On July 22-23, 2024, the Bankruptcy Court held a confirmation hearing to approve the Company’s Third Amended Joint Plan of Invitae Corporation and Its Debtor Affiliates Pursuant to Chapter 11 of the Bankruptcy Code
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Jill Frizzley departed as Director at Invitae Corp.
- Action
- ceased
- Role
- Director
Exact text from the filing
Each of the Company’s directors, Randal W. Scott, PhD, Eric Aguiar, M.D., Jill Frizzley, Geoffrey S. Crouse, Christine M. Gorjanc, Kenneth D. Knight, Kimber D. Lockhart, Chitra Nayak, and William H. Osborne, and the Company’s remaining officers, including Kenneth D. Knight, Chief Executive Officer, Ana J. Schrank, Chief Financial Officer, Thomas R. Brida, General Counsel, Chief Compliance Officer and Secretary, and David B. Sholehvar, M.D., Chief Operating Officer, ceased being directors and officers of the Company on the Effective Date.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Randal W. Scott departed as Director at Invitae Corp.
- Action
- ceased
- Role
- Director
Exact text from the filing
Each of the Company’s directors, Randal W. Scott, PhD, Eric Aguiar, M.D., Jill Frizzley, Geoffrey S. Crouse, Christine M. Gorjanc, Kenneth D. Knight, Kimber D. Lockhart, Chitra Nayak, and William H. Osborne, and the Company’s remaining officers, including Kenneth D. Knight, Chief Executive Officer, Ana J. Schrank, Chief Financial Officer, Thomas R. Brida, General Counsel, Chief Compliance Officer and Secretary, and David B. Sholehvar, M.D., Chief Operating Officer, ceased being directors and officers of the Company on the Effective Date.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Ana J. Schrank departed as Chief Financial Officer at Invitae Corp.
- Action
- ceased
- Role
- Chief Financial Officer
Exact text from the filing
Each of the Company’s directors, Randal W. Scott, PhD, Eric Aguiar, M.D., Jill Frizzley, Geoffrey S. Crouse, Christine M. Gorjanc, Kenneth D. Knight, Kimber D. Lockhart, Chitra Nayak, and William H. Osborne, and the Company’s remaining officers, including Kenneth D. Knight, Chief Executive Officer, Ana J. Schrank, Chief Financial Officer, Thomas R. Brida, General Counsel, Chief Compliance Officer and Secretary, and David B. Sholehvar, M.D., Chief Operating Officer, ceased being directors and officers of the Company on the Effective Date.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Thomas R. Brida departed as General Counsel, Chief Compliance Officer and Secretary at Invitae Corp.
- Action
- ceased
- Role
- General Counsel, Chief Compliance Officer and Secretary
Exact text from the filing
Each of the Company’s directors, Randal W. Scott, PhD, Eric Aguiar, M.D., Jill Frizzley, Geoffrey S. Crouse, Christine M. Gorjanc, Kenneth D. Knight, Kimber D. Lockhart, Chitra Nayak, and William H. Osborne, and the Company’s remaining officers, including Kenneth D. Knight, Chief Executive Officer, Ana J. Schrank, Chief Financial Officer, Thomas R. Brida, General Counsel, Chief Compliance Officer and Secretary, and David B. Sholehvar, M.D., Chief Operating Officer, ceased being directors and officers of the Company on the Effective Date.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Eric Aguiar departed as Director at Invitae Corp.
- Action
- ceased
- Role
- Director
Exact text from the filing
Each of the Company’s directors, Randal W. Scott, PhD, Eric Aguiar, M.D., Jill Frizzley, Geoffrey S. Crouse, Christine M. Gorjanc, Kenneth D. Knight, Kimber D. Lockhart, Chitra Nayak, and William H. Osborne, and the Company’s remaining officers, including Kenneth D. Knight, Chief Executive Officer, Ana J. Schrank, Chief Financial Officer, Thomas R. Brida, General Counsel, Chief Compliance Officer and Secretary, and David B. Sholehvar, M.D., Chief Operating Officer, ceased being directors and officers of the Company on the Effective Date.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Kimber D. Lockhart departed as Director at Invitae Corp.
- Action
- ceased
- Role
- Director
Exact text from the filing
Each of the Company’s directors, Randal W. Scott, PhD, Eric Aguiar, M.D., Jill Frizzley, Geoffrey S. Crouse, Christine M. Gorjanc, Kenneth D. Knight, Kimber D. Lockhart, Chitra Nayak, and William H. Osborne, and the Company’s remaining officers, including Kenneth D. Knight, Chief Executive Officer, Ana J. Schrank, Chief Financial Officer, Thomas R. Brida, General Counsel, Chief Compliance Officer and Secretary, and David B. Sholehvar, M.D., Chief Operating Officer, ceased being directors and officers of the Company on the Effective Date.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
William H. Osborne departed as Director at Invitae Corp.
- Action
- ceased
- Role
- Director
Exact text from the filing
Each of the Company’s directors, Randal W. Scott, PhD, Eric Aguiar, M.D., Jill Frizzley, Geoffrey S. Crouse, Christine M. Gorjanc, Kenneth D. Knight, Kimber D. Lockhart, Chitra Nayak, and William H. Osborne, and the Company’s remaining officers, including Kenneth D. Knight, Chief Executive Officer, Ana J. Schrank, Chief Financial Officer, Thomas R. Brida, General Counsel, Chief Compliance Officer and Secretary, and David B. Sholehvar, M.D., Chief Operating Officer, ceased being directors and officers of the Company on the Effective Date.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Kenneth D. Knight departed as Chief Executive Officer at Invitae Corp.
- Action
- ceased
- Role
- Chief Executive Officer
Exact text from the filing
Each of the Company’s directors, Randal W. Scott, PhD, Eric Aguiar, M.D., Jill Frizzley, Geoffrey S. Crouse, Christine M. Gorjanc, Kenneth D. Knight, Kimber D. Lockhart, Chitra Nayak, and William H. Osborne, and the Company’s remaining officers, including Kenneth D. Knight, Chief Executive Officer, Ana J. Schrank, Chief Financial Officer, Thomas R. Brida, General Counsel, Chief Compliance Officer and Secretary, and David B. Sholehvar, M.D., Chief Operating Officer, ceased being directors and officers of the Company on the Effective Date.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Chitra Nayak departed as Director at Invitae Corp.
- Action
- ceased
- Role
- Director
Exact text from the filing
Each of the Company’s directors, Randal W. Scott, PhD, Eric Aguiar, M.D., Jill Frizzley, Geoffrey S. Crouse, Christine M. Gorjanc, Kenneth D. Knight, Kimber D. Lockhart, Chitra Nayak, and William H. Osborne, and the Company’s remaining officers, including Kenneth D. Knight, Chief Executive Officer, Ana J. Schrank, Chief Financial Officer, Thomas R. Brida, General Counsel, Chief Compliance Officer and Secretary, and David B. Sholehvar, M.D., Chief Operating Officer, ceased being directors and officers of the Company on the Effective Date.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
David B. Sholehvar departed as Chief Operating Officer at Invitae Corp.
- Action
- ceased
- Role
- Chief Operating Officer
Exact text from the filing
Each of the Company’s directors, Randal W. Scott, PhD, Eric Aguiar, M.D., Jill Frizzley, Geoffrey S. Crouse, Christine M. Gorjanc, Kenneth D. Knight, Kimber D. Lockhart, Chitra Nayak, and William H. Osborne, and the Company’s remaining officers, including Kenneth D. Knight, Chief Executive Officer, Ana J. Schrank, Chief Financial Officer, Thomas R. Brida, General Counsel, Chief Compliance Officer and Secretary, and David B. Sholehvar, M.D., Chief Operating Officer, ceased being directors and officers of the Company on the Effective Date.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Geoffrey S. Crouse departed as Director at Invitae Corp.
- Action
- ceased
- Role
- Director
Exact text from the filing
Each of the Company’s directors, Randal W. Scott, PhD, Eric Aguiar, M.D., Jill Frizzley, Geoffrey S. Crouse, Christine M. Gorjanc, Kenneth D. Knight, Kimber D. Lockhart, Chitra Nayak, and William H. Osborne, and the Company’s remaining officers, including Kenneth D. Knight, Chief Executive Officer, Ana J. Schrank, Chief Financial Officer, Thomas R. Brida, General Counsel, Chief Compliance Officer and Secretary, and David B. Sholehvar, M.D., Chief Operating Officer, ceased being directors and officers of the Company on the Effective Date.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Christine M. Gorjanc departed as Director at Invitae Corp.
- Action
- ceased
- Role
- Director
Exact text from the filing
Each of the Company’s directors, Randal W. Scott, PhD, Eric Aguiar, M.D., Jill Frizzley, Geoffrey S. Crouse, Christine M. Gorjanc, Kenneth D. Knight, Kimber D. Lockhart, Chitra Nayak, and William H. Osborne, and the Company’s remaining officers, including Kenneth D. Knight, Chief Executive Officer, Ana J. Schrank, Chief Financial Officer, Thomas R. Brida, General Counsel, Chief Compliance Officer and Secretary, and David B. Sholehvar, M.D., Chief Operating Officer, ceased being directors and officers of the Company on the Effective Date.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.